Euro Gen HGH Fragment 176 191, 5mg

Euro Gen HGH Fragment 176 191, 5mg

Euro-Gen

Research-use-only peptide; human growth hormone fragment
  • Express Peptides states that its peptides, including Euro Gen Branded products, are manufactured in the UK and that each peptide has a minimum purity of >99%, supported by rigorous independent third Party laboratory testing to confirm composition and purity
  • The company indicates that Certificates of Analysis (COAs) are available on request for each peptide batch, providing analytical confirmation of key quality parameters; these COAs are not published online for Euro Gen HGH Fragment 176 191, 5mg but are stated to be accessible to customers
  • Express Peptides describes strict temperature Controlled handling and logistics from production through dispatch to maintain peptide integrity, as well as secure packaging aimed at preserving product condition during shipping
  • No UK MHRA medicinal marketing authorisation (Product Licence), EMA EPAR, FDA approval or other medicinal product authorisation is listed for Euro Gen HGH Fragment 176 191, 5mg, and it is not described as a CE or UKCA Marked medical device; it is marketed solely as a research Use Only peptide reagent
Synthetic peptide fragment of human growth hormone (GH) for in vitro and laboratory research

Description

Euro-Gen HGH Fragment 176-191, 5mg is a research-grade peptide product supplied by Express Peptides under the Euro-Gen brand. It contains 5 mg of human growth hormone fragment 176–191 (HGH Fragment 176-191), a synthetic peptide derived from the C-terminal region of the human growth hormone molecule. Express Peptides describes HGH Fragment 176-191 as a synthetic peptide derived from a larger growth hormone molecule that is studied for its potential to reduce body fat without affecting muscle growth, with research focusing on targeted fat loss, particularly in abdominal regions, while minimising effects on other aspects of growth hormone activity. The product page lists the structure as C₇₈H₁₂₃N₂₃O₂₂S₂ and gives synonyms including “Somatotropin” and “HGH (176-191)”, linking to a PubChem entry for Fragment 176-191. The product is marketed explicitly for in vitro testing and laboratory research only, with clear labelling that it is not a drug, food, or cosmetic and must not be introduced into humans or animals. Express Peptides indicates that its peptides are manufactured in the UK to a minimum purity of >99% and are subject to independent third-party laboratory testing, with Certificates of Analysis available on request.

Bnefits

  • Provides a research-grade preparation of human growth hormone fragment 176–191 (HGH Fragment 176-191) for use in controlled in vitro and laboratory studies on growth hormone–related pathways and energy metabolism
  • Supplies a defined 5 mg quantity of HGH Fragment 176-191 per Euro-Gen-branded vial, supporting reproducible dosing calculations in experimental protocols
  • Express Peptides states that all of its peptides, including Euro-Gen products, are manufactured in the UK with a minimum purity of >99% and are verified by independent third-party laboratory testing, with Certificates of Analysis available upon request
  • The Express Peptides information centre describes HGH Fragment 176-191 as a synthetic peptide derived from a larger growth hormone molecule studied for its potential to reduce body fat without affecting muscle growth, particularly focusing on abdominal fat, providing a clear research rationale for metabolic and body-composition studies
  • Supplied as a lyophilised (powder) peptide suitable for long-term storage under low-temperature conditions and subsequent reconstitution for in vitro research
  • Marketed exclusively for in vitro testing and laboratory research, with explicit warnings that it is not a medicinal product and must not be used in humans or animals, helping to ensure regulatory separation from therapeutic use

Indications

  • Designated use on the Express Peptides product page: for in vitro testing and laboratory research only
  • The Express Peptides site emphasises that this product is exclusively for research purposes, with any form of bodily introduction into humans or animals strictly prohibited by law
  • Used in experimental and preclinical research (not as this specific commercial unit but as the same peptide fragment) to investigate growth hormone fragment biology, including fat metabolism and signalling pathways associated with growth hormone and energy balance
  • Included in Express Peptides’ catalogue under HGH Fragment 176-191 with a product summary describing research interest in targeted fat loss, especially abdominal fat, while minimising broader growth hormone–related effects, supporting use in metabolic and body-composition research models
  • No approved clinical or therapeutic indications are listed for Euro-Gen HGH Fragment 176-191, 5mg; it is not licensed as a medicinal product

Composition

  • Active substance: human growth hormone fragment 176-191 (HGH Fragment 176-191), a synthetic peptide derived from the C-terminal region of human growth hormone
  • Express Peptides lists for Fragment 176-191 the structure: C₇₈H₁₂₃N₂₃O₂₂S₂ and synonyms including “Somatotropin” and “HGH (176-191)” with a link to a PubChem profile for Fragment 176-191
  • Other research peptide suppliers describe HGH Fragment 176-191 with molecular formula values in the range C₇₈H₁₂₃–₁₂₅N₂₃O₂₂–₂₃S or S₂ and a molecular weight around 1815 g/mol, reflecting minor differences based on counter-ion and hydration state; the Express Peptides product page does not list molecular weight explicitly but provides the structural formula notation
  • A representative technical data sheet from another UK research peptide supplier (e.g. OP Labs/Oxford Peptides) specifies the amino acid sequence for HGH Fragment 176-191 as Tyr–Arg–Lys–Asp–Arg–Phe–Phe–Gly–Phe–Ser–Pro–Phe–Arg–Leu–Ser–Arg–Ala, corresponding to residues 176–191 of human growth hormone with a tyrosine at the N-terminus
  • The Euro-Gen HGH Fragment 176-191, 5mg vial is stated to contain 5 mg of lyophilised peptide; no excipients, stabilisers, preservatives, or buffer components are listed on the Express Peptides product page or associated catalogue entries
  • Certificates of Analysis (COAs) and Safety Data Sheets (SDS) are indicated as available on request from Express Peptides but are not publicly posted for this specific product; therefore, lot-specific analytical details (such as exact peptide purity by HPLC, residual solvents, and counter-ion content) are not publicly listed

Formulation

  • Product type: synthetic peptide fragment (HGH Fragment 176-191) supplied as a research-use-only reagent
  • Strength: 5 mg of HGH Fragment 176-191 per vial
  • Physical form: lyophilised (powder) peptide; Express Peptides’ FAQ describes its peptides in general as lyophilised powder products intended to be stored frozen and reconstituted with suitable diluents for research use
  • General appearance for similar HGH Fragment 176-191 research peptides from other suppliers is described as a white to off-white lyophilised solid, consistent with typical peptide formulations; the Express Peptides Euro-Gen product page uses vial imagery but does not provide a formal physical description
  • Class: research peptide fragment of human growth hormone (growth hormone fragment 176–191) used for studies on growth hormone signalling, energy metabolism, and related pathways
  • No specific excipients, preservatives, or additional formulation components (such as mannitol or buffers) are publicly described for the Euro-Gen HGH Fragment 176-191, 5mg vial

Packaging

  • Supplied as a single Euro-Gen-branded vial containing 5 mg of HGH Fragment 176-191, as shown in the product imagery used by Express Peptides and by retail partners such as dermafillerltd.uk
  • The Dermafiller listing for Euro-Gen HGH Fragment 176-191, 5mg presents the product as an individual vial sold at a price point of approximately £29.00 (often shown as £29.00 with promotional reductions), but does not provide additional packaging details such as box materials or inserts
  • Express Peptides’ own product page for Euro-Gen HGH Fragment 176-191, 5mg lists the product as a single vial at 5 mg, with options for free or expedited delivery, but does not describe carton artwork, tamper-evident features, or secondary packaging components
  • General Express Peptides information indicates that products are shipped under temperature-controlled conditions with secure packaging to preserve peptide integrity, but no product-specific packaging specifications (such as closure type, stopper material or vial glass type) are publicly listed for this SKU

Usage

  • Express Peptides explicitly states on the product page for Euro-Gen HGH Fragment 176-191, 5mg that it is for research use only and exclusively designated for in vitro testing and laboratory research; any form of bodily introduction into humans or animals is strictly prohibited by law
  • The same page clarifies that the product is not a drug, food, or cosmetic and must not be misrepresented, misused, or mislabelled as such, and that it is intended only to be handled by licensed and qualified professionals in appropriate research settings
  • Express Peptides’ FAQ explains that peptides can be reconstituted with various solvents depending on their hydrophilic or hydrophobic properties and pH characteristics, mentioning saline, bacteriostatic water, and acetic acid as common options, but it does not give product-specific reconstitution volumes or experimental protocols for Euro-Gen HGH Fragment 176-191, 5mg
  • The FAQ also refers researchers to an online dosage calculator for assistance in determining research dosages, but any calculations and protocols are left to the researcher’s own standard operating procedures and local regulatory requirements, with no clinical dosing guidance provided or authorised
  • After reconstitution, Express Peptides advises that peptides should be stored at 4°C (refrigerated) and used within a few weeks, with care taken to minimise storage time in solution and to avoid repeated freeze–thaw cycles
  • There are no instructions for therapeutic administration, route of administration, or treatment regimens; all guidance is framed strictly around laboratory handling, storage, and reconstitution for research

Contraindications

  • Not a medical product

Adverse Effects

  • Not a medical product

Storage Conditions

  • Express Peptides’ FAQ states that lyophilised (powder) peptides should be stored at -20°C to -80°C, with a shelf life of up to 2 years or more under these conditions
  • Guidance from the same FAQ provides a storage table indicating that lyophilised peptide powder can be stored at room temperature (20–25°C) for about 1 month, in a refrigerator (2–8°C) for approximately 12 months, at -20°C for up to 48 months, and at -80°C for long-term storage
  • After reconstitution, Express Peptides recommends storing peptides at 2–8°C (refrigerated), protecting them from light and moisture, and using them within a period of roughly 2 weeks to 2 months depending on conditions, while avoiding repeated freeze–thaw cycles
  • The FAQ further advises that peptide vials should be kept capped, in a cool, dry place away from light and moisture, and that once a vial cap is removed, immediate use is recommended with avoidance of prolonged storage after opening; dark storage or packaging that protects from light exposure is recommended for optimal stability
  • These storage recommendations apply generally to all Express Peptides lyophilised peptide products and are not modified specifically for Euro-Gen HGH Fragment 176-191, 5mg in publicly available documentation

Duration

Not a medical product

Onset

Not a medical product

Browse more Research-use-only peptide; human growth hormone fragment

Top Treatments

Top Cities in the UK